Pediatric Helmet CPAP Pilot Study

Status Recruiting

Clinical Trial Summary

This a research study to find out whether giving Continuous Positive Airway Pressure (CPAP) through a Helmet is the same or better than giving CPAP through a Facemask, Nasal Mask, or Nasal Prongs. CPAP can help kids with lung infections breathe easier. The machine delivers pressurized air, which may help people with lung infections breathe more easily. Doctors routinely use a Facemask, Nasal Mask or Nasal Prongs to give CPAP for kids with lung infections, but the researchers want to know whether using Helmet CPAP is the same or better.

Clinical Trial Description

Prior clinical trials have demonstrated efficacy of Helmet CPAP in adults with acute respiratory distress syndrome, superior tolerance and improved respiratory scores compared to nasal/facial CPAP in infants, and no major safety concerns were identified with the use of helmet CPAP. This is a prospective pilot study to (1) determine if infants and pediatric patients requiring CPAP in the PICU will tolerate helmet CPAP for at least four hours, and (2) measure changes in the respiratory rate, oxygen saturation, heart rate and blood pressure over four hours. If helmet CPAP is found to be well tolerated in this small cohort, a larger study comparing it directly to other CPAP interfaces will be conducted. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04764929
Study type	Interventional
Source	Columbia University
Contact
Status	Recruiting
Phase	N/A
Start date	August 7, 2021
Completion date	September 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04517123` - Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The "PRONE" Study	N/A
Completed	`NCT04435327` - Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Completed	`NCT01271842` - Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study	N/A
Completed	`NCT04724538` - Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19	Phase 1/Phase 2
Recruiting	`NCT04414293` - Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis	N/A
Completed	`NCT04047719` - Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens
Recruiting	`NCT04528888` - Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection	Phase 3
Completed	`NCT04606407` - Inhaled NO for the Treatment of Viral Pneumonia in Adults	N/A
Terminated	`NCT04619693` - Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia
Recruiting	`NCT05077917` - Cromolyn Sodium for Treatment of COVID-19 Pneumonia	Phase 3
Withdrawn	`NCT04381923` - COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia	N/A
Recruiting	`NCT05976581` - Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients	N/A
Active, not recruiting	`NCT04381364` - Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)	Phase 2
Completed	`NCT04422613` - Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia	N/A
Completed	`NCT04479540` - Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease	N/A
Recruiting	`NCT04474340` - COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients	Phase 1
Completed	`NCT04424836` - HFNC Treatment in COVID-19 Pneumonia
Active, not recruiting	`NCT04365101` - Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19	Phase 1/Phase 2
Completed	`NCT04387799` - Determinants of COVID-19 Pneumonia (MC-19)
Completed	`NCT04382547` - Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells	Phase 1/Phase 2